Feedback

Pfizer vaccine shows its efficacy against new Covid-19 strain

Source : 112 Ukraine

The vaccine trains the body to recognize the relevant spike protein and fight it
18:23, 8 January 2021

AP

Pfizer's coronavirus vaccine has proved its effectiveness against the new mutated strain of coronavirus infection that was found in the UK and South Africa, AP reports.

The strain has a mutation called N501Y - a slight alteration on one spot of the spike protein that forces more aggressive contagiousness. Most vaccines available around the world train the body to recognize that spike protein and fight it.

Pfizer teamed up with researchers from the University of Texas at Galveston's medical department for laboratory tests to see if the mutation affected the vaccine's ability to do so.

Related: Europe is botching the vaccine rollout

As we reported earlier, French Health Minister Olivier Veran announced the expansion, acceleration, and simplification of the coronavirus vaccination program.

According to Veran, by the end of January, France will have begun vaccinating people aged 75 and above who are living at home.

The country initially received 500,000 doses of the vaccine developed by Pfizer Inc and Germany’s BioNTech SE and was due to receive an additional 500,000 per week.

Related: EU health authority approves Moderna Covid-19 vaccine

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more